Variations in prognostic factors in primary breast cancer throughout the menstrual cycle

European Journal of Surgical Oncology

Volumn 26, Issue 1, 2000, Pages 11-16

  Kroman, N ^a,b   Thorpe, S M ^a   Wohlfahrt, J ^b   Andersen, K W ^a   Mouridsen, H T ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

Author keywords

Breast cancer; Menstrual cycle; Oestrogen receptor; Progesterone receptor; Prognostic factors

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; DENMARK; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MITOSIS INDEX; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

EID: 0033956732     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0732     Document Type: Article

References (31)

1. Ferguson DJP, Anderson TJ. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br J Cancer. 44:1981;177-181.
2. Potten CS, Watson RJ, Williams GT. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer. 58:1988;163-170.
3. Going JJ, Anderson TJ, Battersby S, Macintyre CCA. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol. 130:1988;193-204.
4. Olsson H, Jernström H, Alm P. Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast Cancer Res Treat. 40:1996;187-196.
5. Vogel PM, Georgiade NG, Fetter BF, Vogel S, McCarty KS. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol. 104:1981;23-34.
6. Axelrod DM, Menendez-Botet CJ, Kinne DW, Osborne MP. Levels of estrogen and progesterone receptor proteins in patients with breast cancer during various phases of the menses. Cancer Invest. 6:1988;7-14.
7. Coradini D, Cappelletti V, Miodini P. Variations in estrogen and progesterone receptor content in premenopausal breast cancer patients throughout the menstrual cycle. Tumori. 70:1984;339-344.
8. Heise E, Görlich M. Estradiol receptor in human breast cancers throughout the menstrual cycle. Oncology. 39:1982;340-344.
9. Smyth CM, Benn DE, Reeve TS. Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies. Breast Cancer Res treat. 11:1988;45-50.
10. Saez S, Chouvet C. Influence of endogenous hormone levels on tumor estradiol and progesterone receptors. Recent Results Cancer Res. 91:1984;150-156.
11. Weimer DA, Donegan WL. Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle. Breast Cancer Res Treat. 10:1987;273-278.
12. Pujol P, Daures JP, Thezenas S. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause. Cancer. 83:1998;698-705.
13. Saez S, Martin PM, Couvet C. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels. Cancer Res. 38:1978;3468-3473.
14. Badwe RA, Richards MA, Fentiman IS. Surgical procedures, menstrual cycle phase, and prognosis in operable breast cancer. Lancet. 338:1991;815-816.
15. Veronesi U, Luini A, Mariani L. Effect of menstrual phase on surgical treatment of breast cancer. Lancet. 343:1994;1545-1547.
16. Cooper, A, In: Lee A (ed.) The Principles and Practice of Surgery. London, 1836, 327, 31.
17. Oliver DJ, Ingram DM. Timing of surgery during the menstrual cycle for breast cancer: possible role of growth factors. Eur J Cancer. 31A:1995;325-328.
18. Sigurdsson, H, Indicators of prognosis in breast cancer. In Thesis. Lund: Sweden, 1992.
19. Silvestrini R, Luisi A, Daidone MG, DiMauro MG. Effect of menstrual phase on cell proliferative rate of breast cancer. Breast Cancer Res Treat. 48:1998;93-94.
20. Rageth JC, Wyss P, Unger C, Hochuli E. Timing of breast cancer surgery within the menstrual cycle: influence on lymph-node involvement, receptor status, postoperative metastatic spread and local recurrence. Ann Oncol. 2:1991;269-272.
21. Badwe RA, Bettelheim R, Millis RR. Cyclical tumour variations in premenopausal women with early breast cancer. Eur J Cancer. 31A:1995;2181-2184.
22. Kroman N, Hojgaard A, Andersen KW. Timing of surgery in relation to menstrual cycle does not predict the prognosis in primary breast cancer. Danish Breast Cancer Cooperative Group. Eur J Surg Oncol. 20:1994;430-435.
23. Andersen KW, Mouridsen HT. Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncologica. 27:1988;627-643.
24. Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci. 51:1949;660-672.
25. Thorpe SM. Steroid receptors in breast cancer: sources of inter-laboratory variation in dextran-charcoal assays. Breast Cancer Res Treat. 9:1987;175-189.
26. Koenders A, Thorpe SM. Standardization of steroid receptor assays in human breast cancer-IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays. Eur J Cancer Clin Oncol. 22:1986;945-952.
27. Hawkins RA, Roberts MM, Forrest APM. Oestrogen receptors and breast cancer: current status. Br J Surg. 67:1980;153-169.
28. Nagai R, Kataoka M, Kobayashi S. Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels. Cancer Res. 39:1979;1835-1840.
29. Randal J. Does the timing of breast cancer surgery affect survival? [news]. J Natl Cancer Inst. 89:1997;473-477.
30. Hagen AA, Hrushesky WJ. Menstrual timing of breast cancer surgery. Am J Surg. 175:1998;245-261.
31. Landgren BM, Undén AL, Diczfalusy E. Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinol Copenh. 94:1980;89-98.